Watching other people reap the benefits of GLP-1s may trigger a little FOMO if you have type 1 diabetes. While these medications still aren’t approved for people with T1D, that gap may finally be starting to close. Here’s the latest research, potential benefits, and real reasons to be optimistic.
read more →
Now that we have a few oral GLP-1 medications on the market with more on the way, inquiring minds want to know if they’re as effective as the injections. Dr. E dives into the research and explains why the answer isn’t as straightforward as you might think.
read more →
2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
read more →
Over the last two years, there’s been conflicting information in the news about GLP-1 medications and mental health. Some reports raised concerns about possible mood-related side effects, but others shared mental health benefits and broader therapeutic potential. Here’s what we know so far – and what still needs further research.
read more →
Ozempic and Mounjaro are similar in many ways, but there’s one key difference between the two. Learn how these blockbuster type 2 diabetes medications are changing the landscape of diabetes management, and find out why they aren’t yet approved for use in type 1.
read more →
